Delivery Order SPE2DR25D3202-SPE2DR26F8E4W
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,217.64 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This is a firm fixed-price, non-set-aside contract awarded on January 9, 2026, with an ultimate completion date of January 12, 2026. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order represents a task order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $14,484.65 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This is a firm fixed-price, competitive award with no set-aside designation, with an ultimate completion date of November 7, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,899.35 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 25, 2025, one day after the award date. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,675.25 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance to be completed by January 14, 2026, and fulfillment occurring at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for Proctofoam-HC 1%-1% Foam in a 10-gram formulation, with a ceiling value of $1,110.89. This is a firm fixed-price delivery order with no set-aside designation, performed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,745.98 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 10, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the...
- The Defense Logistics Agency awarded a $11,418.86 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Proctofoam-HC 1%-1% foam (10 grams) under a firm fixed-price contract with a ceiling value of $1,799.37. The contract is non-set-aside and competitively awarded, with an ultimate completion date of January 6, 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a $1,455.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a non-set-aside contract with an ultimate completion date of November 6, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $1,077.91 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram quantity, with an ultimate completion date of May 7, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product is being delivered to Conshohocken, Pennsylvania, where...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E4WDelivery Order
The Defense Logistics Agency awarded a $1,998.61 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This is a firm fixed-price, non-set-aside contract with a completion date of January 13, 2026, and performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at $999,999,999.00 through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that supplies a broad range of medical products to federal agencies, with a particular focus on military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling competitively awarded delivery orders for pharmaceutical and medical supply needs across multiple therapeutic domains. This delivery order exemplifies the routine pharmaceutical procurement conducted through the DLA Troop Support Medical contract vehicle, which enables flexible and efficient supply of critical medical commodities to support federal healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/11/26 |